StonvexLoading…
StonvexStonvexStonvexCore line items from RDZN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 |
|---|---|---|---|
Revenue | $44.30M | $46.72M | $13.56M |
Operating Income | $-60.81M | $-77.66M | $-11.53M |
Net Income | $-72.87M | $-99.67M | $-14.02M |
EPS (Diluted) | $-1.04 | $-2.26 | $-0.86 |
Total Assets | $32.58M | $58.14M | $15.18M |
Total Liabilities | $58.27M | $68.64M | $17.99M |
Cash & Equivalents | $4.84M | $11.19M | $589.34K |
Free Cash Flow OCF − CapEx | $-18.57M | $-19.67M | $-8.39M |
Shares Outstanding | 74.29M | 68.44M | 16.50M |